Cellectis Ownership 2024 | Who Owns Cellectis Now?
Institutional Ownership
2.30%
Insider Ownership
9.39%
Retail Ownership
88.31%
Institutional Holders
11.00
Cellectis Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 6.43% | 0.33% | 4,617,293 | 130,000 | 2.90% | 8,634,338 | Jun 30, 2024 |
| CAPITAL INTERNATIONAL INVESTORS | 2.57% | 0.00% | 1,848,804 | - | - | 3,457,263 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 2.00% | 0.00% | 1,438,255 | 1,438,255 | 100.00% | 2,689,537 | Jun 30, 2024 |
| BAILLIE GIFFORD & CO | 0.99% | 0.00% | 707,630 | -119,618 | -14.46% | 1,323,268 | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | 0.61% | 0.00% | 437,000 | 12,467 | 2.94% | 817,190,000 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.32% | 0.00% | 226,875 | - | - | 424,000 | Jun 30, 2024 |
| KBC GROUP NV | 0.23% | 0.00% | 163,447 | - | - | 306,000 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.13% | 0.00% | 91,787 | 10,440 | 12.83% | 171,642 | Jun 30, 2024 |
| MORGAN STANLEY | 0.12% | - | 86,325 | 2,180 | 2.59% | 161,429 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.06% | 0.00% | 40,289 | -9,591 | -19.23% | 75,340 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.02% | - | 16,700 | -100 | -0.60% | 31,229 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.02% | 0.00% | 15,320 | 15,320 | 100.00% | 28,648 | Jun 30, 2024 |
| BAIRD FINANCIAL GROUP, INC. | 0.02% | 0.00% | 15,090 | 15,090 | 100.00% | 28,218 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.02% | - | 12,790 | -150 | -1.16% | 23,917 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.01% | - | 10,776 | - | - | 20,151 | Jun 30, 2024 |
| HARBOUR INVESTMENTS, INC. | 0.01% | 0.00% | 6,100 | - | - | 11,407 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.01% | - | 3,855 | - | - | 7,207 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.01% | - | 3,600 | - | - | 6,884 | Jun 30, 2024 |
| BLACKROCK INC. | 0.00% | - | 2,755 | - | - | 5,152 | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | 0.00% | - | 500 | - | - | 1,015 | Jun 30, 2024 |
Cellectis's largest institutional shareholder is LONG FOCUS CAPITAL MANAGEMENT, LLC, holding 6.43% of the company's total share outstanding, currently valued at $8.63M. The top 10 institutional shareholders own together 13.45% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 6.43% | 0.33% | 4,617,293 | 130,000 | 2.90% | 8,634,338 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.02% | 0.00% | 15,320 | 15,320 | 100.00% | 28,648 | Jun 30, 2024 |
| BAILLIE GIFFORD & CO | 0.99% | 0.00% | 707,630 | -119,618 | -14.46% | 1,323,268 | Jun 30, 2024 |
| KBC GROUP NV | 0.23% | 0.00% | 163,447 | - | - | 306,000 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 2.00% | 0.00% | 1,438,255 | 1,438,255 | 100.00% | 2,689,537 | Jun 30, 2024 |
| POM INVESTMENT STRATEGIES, LLC | 0.00% | 0.00% | 495 | - | - | 926 | Jun 30, 2024 |
| CAPITAL INTERNATIONAL INVESTORS | 2.57% | 0.00% | 1,848,804 | - | - | 3,457,263 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.32% | 0.00% | 226,875 | - | - | 424,000 | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | 0.61% | 0.00% | 437,000 | 12,467 | 2.94% | 817,190,000 | Jun 30, 2024 |
| HARBOUR INVESTMENTS, INC. | 0.01% | 0.00% | 6,100 | - | - | 11,407 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.06% | 0.00% | 40,289 | -9,591 | -19.23% | 75,340 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.13% | 0.00% | 91,787 | 10,440 | 12.83% | 171,642 | Jun 30, 2024 |
| BAIRD FINANCIAL GROUP, INC. | 0.02% | 0.00% | 15,090 | 15,090 | 100.00% | 28,218 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.02% | - | 16,700 | -100 | -0.60% | 31,229 | Jun 30, 2024 |
| MORGAN STANLEY | 0.12% | - | 86,325 | 2,180 | 2.59% | 161,429 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.01% | - | 3,600 | - | - | 6,884 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.01% | - | 3,855 | - | - | 7,207 | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | 0.00% | - | 500 | - | - | 1,015 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.02% | - | 12,790 | -150 | -1.16% | 23,917 | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | 13 | - | - | 29 | Jun 30, 2024 |
The largest Cellectis shareholder by % of total assets is LONG FOCUS CAPITAL MANAGEMENT, LLC. The company owns 4.62M shares of Cellectis (CLLS), representing 0.33% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| UBS ASSET MANAGEMENT AMERICAS INC | 2.00% | 0.00% | 1,438,255 | 1,438,255 | 100.00% | 2,689,537 | Jun 30, 2024 |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 6.43% | 0.33% | 4,617,293 | 130,000 | 2.90% | 8,634,338 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.02% | 0.00% | 15,320 | 15,320 | 100.00% | 28,648 | Jun 30, 2024 |
| BAIRD FINANCIAL GROUP, INC. | 0.02% | 0.00% | 15,090 | 15,090 | 100.00% | 28,218 | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | 0.61% | 0.00% | 437,000 | 12,467 | 2.94% | 817,190,000 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.13% | 0.00% | 91,787 | 10,440 | 12.83% | 171,642 | Jun 30, 2024 |
| MORGAN STANLEY | 0.12% | - | 86,325 | 2,180 | 2.59% | 161,429 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 83 | - | - | 155 | Jun 30, 2024 |
| TORONTO DOMINION BANK | - | - | 31 | - | - | 58 | Jun 30, 2024 |
| BLACKROCK INC. | 0.00% | - | 2,755 | - | - | 5,152 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.01% | - | 10,776 | - | - | 20,151 | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | 13 | - | - | 29 | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | 0.00% | - | 500 | - | - | 1,015 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.01% | - | 3,855 | - | - | 7,207 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.01% | - | 3,600 | - | - | 6,884 | Jun 30, 2024 |
| HARBOUR INVESTMENTS, INC. | 0.01% | 0.00% | 6,100 | - | - | 11,407 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.32% | 0.00% | 226,875 | - | - | 424,000 | Jun 30, 2024 |
| CAPITAL INTERNATIONAL INVESTORS | 2.57% | 0.00% | 1,848,804 | - | - | 3,457,263 | Jun 30, 2024 |
| POM INVESTMENT STRATEGIES, LLC | 0.00% | 0.00% | 495 | - | - | 926 | Jun 30, 2024 |
| KBC GROUP NV | 0.23% | 0.00% | 163,447 | - | - | 306,000 | Jun 30, 2024 |
As of Jun 30 2024, Cellectis's largest institutional buyer is UBS ASSET MANAGEMENT AMERICAS INC. The company purchased 1.44M stocks of CLLS, valued at $2.69M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| OPPENHEIMER & CO INC | - | - | - | -133,890 | -100.00% | - | Jun 30, 2024 |
| BAILLIE GIFFORD & CO | 0.99% | 0.00% | 707,630 | -119,618 | -14.46% | 1,323,268 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.06% | 0.00% | 40,289 | -9,591 | -19.23% | 75,340 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -1,523 | -100.00% | - | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -1,080 | -100.00% | - | Jun 30, 2024 |
| OLD POINT TRUST & FINANCIAL SERVICES N A | - | - | - | -250 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 112 | -200 | -64.10% | 210 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.02% | - | 12,790 | -150 | -1.16% | 23,917 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.02% | - | 16,700 | -100 | -0.60% | 31,229 | Jun 30, 2024 |
| FRG FAMILY WEALTH ADVISORS LLC | - | - | - | -80 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | 2 | -34 | -94.44% | 4 | Jun 30, 2024 |
| FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
| KBC GROUP NV | 0.23% | 0.00% | 163,447 | - | - | 306,000 | Jun 30, 2024 |
| POM INVESTMENT STRATEGIES, LLC | 0.00% | 0.00% | 495 | - | - | 926 | Jun 30, 2024 |
| CAPITAL INTERNATIONAL INVESTORS | 2.57% | 0.00% | 1,848,804 | - | - | 3,457,263 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.32% | 0.00% | 226,875 | - | - | 424,000 | Jun 30, 2024 |
| HARBOUR INVESTMENTS, INC. | 0.01% | 0.00% | 6,100 | - | - | 11,407 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.01% | - | 3,600 | - | - | 6,884 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.01% | - | 3,855 | - | - | 7,207 | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | 0.00% | - | 500 | - | - | 1,015 | Jun 30, 2024 |
As of Jun 30 2024, Cellectis's biggest institutional seller is OPPENHEIMER & CO INC. The company sold -0.13M shares of CLLS, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| UBS ASSET MANAGEMENT AMERICAS INC | 2.00% | 0.00% | 1,438,255 | 1,438,255 | 100.00% | 2,689,537 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.02% | 0.00% | 15,320 | 15,320 | 100.00% | 28,648 | Jun 30, 2024 |
| BAIRD FINANCIAL GROUP, INC. | 0.02% | 0.00% | 15,090 | 15,090 | 100.00% | 28,218 | Jun 30, 2024 |
Cellectis's largest new institutional shareholder by number of shares is UBS ASSET MANAGEMENT AMERICAS INC, purchased 1.44M shares, valued at $2.69M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| OPPENHEIMER & CO INC | - | - | - | -133,890 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -1,523 | -100.00% | - | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -1,080 | -100.00% | - | Jun 30, 2024 |
| OLD POINT TRUST & FINANCIAL SERVICES N A | - | - | - | -250 | -100.00% | - | Jun 30, 2024 |
| FRG FAMILY WEALTH ADVISORS LLC | - | - | - | -80 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
Cellectis's largest sold out institutional shareholder by shares sold is OPPENHEIMER & CO INC, sold -0.13M shares, valued at -, as of undefined.
Cellectis Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| EntrepreneurShares Series Trust | 0.64% | 170,547 | - | - | Dec 31, 2023 |
| Ark ETF Trust | 0.36% | 2,898,410 | - | - | Jan 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.19% | 226,875 | - | - | Mar 28, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.10% | 47,437 | - | - | Mar 31, 2024 |
| EXCHANGE TRADED CONCEPTS TRUST | 0.06% | 336,812 | - | - | Feb 29, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.04% | 360,000 | - | - | Jan 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.03% | 1,848,804 | - | - | Mar 31, 2024 |
| TOCQUEVILLE TRUST | 0.02% | 2,500 | - | - | Jan 31, 2024 |
| EATON VANCE GROWTH TRUST | 0.02% | 167,117 | - | - | Feb 29, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.01% | 419,451 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.01% | 38,393 | - | - | Mar 31, 2024 |
| Tekla World Healthcare Fund | 0.01% | 11,955 | - | - | Mar 31, 2024 |
| INVESCO BLDRS INDEX FUNDS TRUST | 0.01% | 397 | - | - | Dec 31, 2022 |
| Global X Funds | 0.00% | 207,638 | - | - | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 386,615 | - | - | Jan 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 193,505 | - | - | Feb 29, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 8,946 | - | - | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 107,465 | - | - | Feb 29, 2024 |
| BAILLIE GIFFORD FUNDS | 0.00% | 10,403 | - | - | Mar 28, 2024 |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 0.00% | 37,100 | -8,679 | -18.96% | Mar 31, 2024 |
| OLD WESTBURY FUNDS INC | 0.00% | 118,061 | -28,144 | -19.25% | Jan 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 16,294 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 12,932 | - | - | Mar 28, 2024 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 21,118 | 13,378 | 172.84% | Feb 29, 2024 |
| LAZARD FUNDS INC | 0.00% | 2,315 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 345,733 | -20,864 | -5.69% | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 10,776 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 10,154 | - | - | Jan 31, 2024 |
| Investment Managers Series Trust II | 0.00% | 460 | - | - | Jan 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 3,272 | - | - | Feb 29, 2024 |
| LoCorr Investment Trust | 0.00% | 671 | - | - | Mar 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 7,279 | - | - | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 475 | - | - | Jan 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 660 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 274,920 | - | - | Mar 31, 2024 |
| Franklin Templeton ETF Trust | 0.00% | 1,458 | - | - | Mar 31, 2024 |
| SPDR SERIES TRUST | 0.00% | 263,239 | - | - | Mar 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 400 | - | - | Mar 31, 2023 |
| PROSHARES TRUST | 0.00% | 1,515 | - | - | Feb 29, 2024 |
| LAZARD RETIREMENT SERIES INC | 0.00% | 1,320 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 364 | - | - | Feb 29, 2024 |
| AMERICAN BEACON FUNDS | 0.00% | 12,046 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 335 | - | - | Jan 31, 2024 |
| Goldman Sachs Trust II | 0.00% | 3,377 | - | - | Jan 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 998 | - | - | Dec 31, 2023 |
Cellectis's largest mutual fund holder by % of total assets is "EntrepreneurShares Series Trust", owning 170.55K shares, compromising 0.64% of its total assets.
Cellectis Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 11 | -65.63% |
| 31 Mar, 24 | 32 | -8.57% |
| 31 Dec, 23 | 35 | 12.90% |
| 30 Sep, 23 | 31 | -8.82% |
| 30 Jun, 23 | 34 | 13.33% |
| 31 Mar, 23 | 30 | -25.00% |
| 31 Dec, 22 | 40 | -9.09% |
| 30 Sep, 22 | 44 | 7.32% |
| 30 Jun, 22 | 41 | -21.15% |
| 31 Mar, 22 | 52 | -11.86% |
| 31 Dec, 21 | 59 | -20.27% |
| 30 Sep, 21 | 74 | -9.76% |
| 30 Jun, 21 | 82 | -1.20% |
| 31 Mar, 21 | 83 | -10.75% |
| 31 Dec, 20 | 93 | 25.68% |
| 30 Sep, 20 | 74 | -7.50% |
| 30 Jun, 20 | 80 | 25.00% |
| 31 Mar, 20 | 64 | 4.92% |
| 31 Dec, 19 | 61 | 1.67% |
| 30 Sep, 19 | 60 | -16.67% |
| 30 Jun, 19 | 72 | 12.50% |
| 31 Mar, 19 | 64 | -3.03% |
| 31 Dec, 18 | 66 | -19.51% |
| 30 Sep, 18 | 82 | -5.75% |
| 30 Jun, 18 | 87 | 24.29% |
| 31 Mar, 18 | 70 | 12.90% |
| 31 Dec, 17 | 62 | 29.17% |
| 30 Sep, 17 | 48 | 11.63% |
| 30 Jun, 17 | 43 | 2.38% |
| 31 Mar, 17 | 42 | 10.53% |
| 31 Dec, 16 | 38 | -7.32% |
| 30 Sep, 16 | 41 | 5.13% |
| 30 Jun, 16 | 39 | -11.36% |
| 31 Mar, 16 | 44 | -6.38% |
| 31 Dec, 15 | 47 | 9.30% |
| 30 Sep, 15 | 43 | 7.50% |
| 30 Jun, 15 | 40 | -9.09% |
| 31 Mar, 15 | 44 | - |
As of 30 Jun 24, 11 institutions are holding Cellectis's shares, representing a decrease of -65.63% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 1,652,065 | -83.24% |
| 31 Mar, 24 | 9,854,602 | 0.39% |
| 31 Dec, 23 | 9,816,725 | -14.49% |
| 30 Sep, 23 | 11,480,556 | -18.05% |
| 30 Jun, 23 | 14,008,675 | -7.05% |
| 31 Mar, 23 | 15,071,852 | 72.57% |
| 31 Dec, 22 | 8,733,629 | -15.22% |
| 30 Sep, 22 | 10,300,913 | -5.02% |
| 30 Jun, 22 | 10,845,225 | -11.60% |
| 31 Mar, 22 | 12,268,809 | -19.22% |
| 31 Dec, 21 | 15,188,388 | -1.32% |
| 30 Sep, 21 | 15,391,141 | -5.08% |
| 30 Jun, 21 | 16,214,576 | 6.38% |
| 31 Mar, 21 | 15,242,597 | -6.59% |
| 31 Dec, 20 | 16,317,915 | 14.74% |
| 30 Sep, 20 | 14,221,871 | 2.26% |
| 30 Jun, 20 | 13,907,451 | -3.69% |
| 31 Mar, 20 | 14,439,722 | 9.19% |
| 31 Dec, 19 | 13,224,530 | 0.58% |
| 30 Sep, 19 | 13,148,144 | -2.14% |
| 30 Jun, 19 | 13,435,839 | 5.46% |
| 31 Mar, 19 | 12,740,164 | 10.91% |
| 31 Dec, 18 | 11,487,276 | -0.19% |
| 30 Sep, 18 | 11,509,673 | 2.15% |
| 30 Jun, 18 | 11,267,379 | 59.78% |
| 31 Mar, 18 | 7,051,731 | -3.51% |
| 31 Dec, 17 | 7,308,296 | 24.45% |
| 30 Sep, 17 | 5,872,447 | 11.67% |
| 30 Jun, 17 | 5,258,929 | -7.79% |
| 31 Mar, 17 | 5,703,192 | 0.58% |
| 31 Dec, 16 | 5,670,274 | -14.59% |
| 30 Sep, 16 | 6,638,842 | -4.24% |
| 30 Jun, 16 | 6,932,864 | 7.10% |
| 31 Mar, 16 | 6,473,069 | -8.20% |
| 31 Dec, 15 | 7,051,276 | 2.53% |
| 30 Sep, 15 | 6,877,612 | 4.19% |
| 30 Jun, 15 | 6,601,328 | 7.79% |
| 31 Mar, 15 | 6,124,469 | - |
Cellectis (CLLS) has 1.65M shares outstanding as of 30 Jun 24, down -83.24% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 2.30% | 0.73% |
| 31 Mar, 24 | 17.73% | 5.68% |
| 31 Dec, 23 | 17.66% | 4.14% |
| 30 Sep, 23 | 20.65% | 2.79% |
| 30 Jun, 23 | 27.23% | 3.17% |
| 31 Mar, 23 | 29.29% | 7.97% |
| 31 Dec, 22 | 19.17% | 3.75% |
| 30 Sep, 22 | 22.62% | 3.98% |
| 30 Jun, 22 | 23.83% | 3.28% |
| 31 Mar, 22 | 26.97% | 2.14% |
| 31 Dec, 21 | 35.53% | 3.10% |
| 30 Sep, 21 | 33.85% | 2.66% |
| 30 Jun, 21 | 35.67% | 2.77% |
| 31 Mar, 21 | 35.86% | 2.44% |
| 31 Dec, 20 | 38.31% | 3.42% |
| 30 Sep, 20 | 33.47% | 3.12% |
| 30 Jun, 20 | 32.74% | 2.83% |
| 31 Mar, 20 | 34.02% | 3.51% |
| 31 Dec, 19 | 31.15% | 3.25% |
| 30 Sep, 19 | 30.98% | 3.09% |
| 30 Jun, 19 | 31.66% | 3.24% |
| 31 Mar, 19 | 31.25% | 3.94% |
| 31 Dec, 18 | 28.17% | 3.83% |
| 30 Sep, 18 | 27.14% | 3.81% |
| 30 Jun, 18 | 26.69% | 6.84% |
| 31 Mar, 18 | 19.76% | 4.71% |
| 31 Dec, 17 | 20.48% | 7.66% |
| 30 Sep, 17 | 16.35% | 7.48% |
| 30 Jun, 17 | 14.79% | 5.68% |
| 31 Mar, 17 | 16.14% | 6.27% |
| 31 Dec, 16 | 16.05% | 4.55% |
| 30 Sep, 16 | 18.79% | 4.87% |
| 30 Jun, 16 | 19.64% | 5.84% |
| 31 Mar, 16 | 18.34% | 4.55% |
| 31 Dec, 15 | 20.07% | 5.23% |
| 30 Sep, 15 | 19.60% | 5.52% |
| 30 Jun, 15 | 18.84% | 6.17% |
| 31 Mar, 15 | 17.48% | - |
As of 30 Jun 24, Cellectis is held by 2.30% institutional shareholders, representing a 0.73% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 2 | -83.33% |
| 31 Mar, 24 | 12 | -14.29% |
| 31 Dec, 23 | 14 | 27.27% |
| 30 Sep, 23 | 11 | 22.22% |
| 30 Jun, 23 | 9 | -40.00% |
| 31 Mar, 23 | 15 | -6.25% |
| 31 Dec, 22 | 16 | -15.79% |
| 30 Sep, 22 | 19 | 26.67% |
| 30 Jun, 22 | 15 | -40.00% |
| 31 Mar, 22 | 25 | -16.67% |
| 31 Dec, 21 | 30 | -9.09% |
| 30 Sep, 21 | 33 | 17.86% |
| 30 Jun, 21 | 28 | -39.13% |
| 31 Mar, 21 | 46 | -14.81% |
| 31 Dec, 20 | 54 | 92.86% |
| 30 Sep, 20 | 28 | -41.67% |
| 30 Jun, 20 | 48 | 41.18% |
| 31 Mar, 20 | 34 | 17.24% |
| 31 Dec, 19 | 29 | -9.38% |
| 30 Sep, 19 | 32 | -8.57% |
| 30 Jun, 19 | 35 | -10.26% |
| 31 Mar, 19 | 39 | 25.81% |
| 31 Dec, 18 | 31 | -26.19% |
| 30 Sep, 18 | 42 | -23.64% |
| 30 Jun, 18 | 55 | 30.95% |
| 31 Mar, 18 | 42 | 31.25% |
| 31 Dec, 17 | 32 | 39.13% |
| 30 Sep, 17 | 23 | 21.05% |
| 30 Jun, 17 | 19 | 11.76% |
| 31 Mar, 17 | 17 | -5.56% |
| 31 Dec, 16 | 18 | 12.50% |
| 30 Sep, 16 | 16 | -11.11% |
| 30 Jun, 16 | 18 | - |
| 31 Mar, 16 | 18 | -35.71% |
| 31 Dec, 15 | 28 | 40.00% |
| 30 Sep, 15 | 20 | -25.93% |
| 30 Jun, 15 | 27 | -38.64% |
| 31 Mar, 15 | 44 | - |
2 institutional shareholders have increased their position in CLLS stock as of 30 Jun 24 compared to 12 in the previous quarter (a -83.33% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 1 | -80.00% |
| 31 Mar, 24 | 5 | -28.57% |
| 31 Dec, 23 | 7 | 16.67% |
| 30 Sep, 23 | 6 | -40.00% |
| 30 Jun, 23 | 10 | 42.86% |
| 31 Mar, 23 | 7 | -41.67% |
| 31 Dec, 22 | 12 | -20.00% |
| 30 Sep, 22 | 15 | -21.05% |
| 30 Jun, 22 | 19 | 26.67% |
| 31 Mar, 22 | 15 | -11.76% |
| 31 Dec, 21 | 17 | -15.00% |
| 30 Sep, 21 | 20 | -41.18% |
| 30 Jun, 21 | 34 | 88.89% |
| 31 Mar, 21 | 18 | -25.00% |
| 31 Dec, 20 | 24 | -20.00% |
| 30 Sep, 20 | 30 | 36.36% |
| 30 Jun, 20 | 22 | 29.41% |
| 31 Mar, 20 | 17 | - |
| 31 Dec, 19 | 17 | 13.33% |
| 30 Sep, 19 | 15 | -37.50% |
| 30 Jun, 19 | 24 | 71.43% |
| 31 Mar, 19 | 14 | -33.33% |
| 31 Dec, 18 | 21 | 10.53% |
| 30 Sep, 18 | 19 | 46.15% |
| 30 Jun, 18 | 13 | -7.14% |
| 31 Mar, 18 | 14 | 40.00% |
| 31 Dec, 17 | 10 | 11.11% |
| 30 Sep, 17 | 9 | -18.18% |
| 30 Jun, 17 | 11 | 22.22% |
| 31 Mar, 17 | 9 | - |
| 31 Dec, 16 | 9 | -10.00% |
| 30 Sep, 16 | 10 | 11.11% |
| 30 Jun, 16 | 9 | -30.77% |
| 31 Mar, 16 | 13 | 18.18% |
| 31 Dec, 15 | 11 | 10.00% |
| 30 Sep, 15 | 10 | 66.67% |
| 30 Jun, 15 | 6 | - |
| 31 Mar, 15 | - | - |
1 institutional shareholders have reduced their position in CLLS stock as of 30 Jun 24 compared to 5 in the previous quarter (a -80.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 11 | -65.63% | 1,652,065 | -83.24% | 2.30% | 0.73% | 2 | -83.33% | 1 | -80.00% |
| 31 Mar, 24 | 32 | -8.57% | 9,854,602 | 0.39% | 17.73% | 5.68% | 12 | -14.29% | 5 | -28.57% |
| 31 Dec, 23 | 35 | 12.90% | 9,816,725 | -14.49% | 17.66% | 4.14% | 14 | 27.27% | 7 | 16.67% |
| 30 Sep, 23 | 31 | -8.82% | 11,480,556 | -18.05% | 20.65% | 2.79% | 11 | 22.22% | 6 | -40.00% |
| 30 Jun, 23 | 34 | 13.33% | 14,008,675 | -7.05% | 27.23% | 3.17% | 9 | -40.00% | 10 | 42.86% |
| 31 Mar, 23 | 30 | -25.00% | 15,071,852 | 72.57% | 29.29% | 7.97% | 15 | -6.25% | 7 | -41.67% |
| 31 Dec, 22 | 40 | -9.09% | 8,733,629 | -15.22% | 19.17% | 3.75% | 16 | -15.79% | 12 | -20.00% |
| 30 Sep, 22 | 44 | 7.32% | 10,300,913 | -5.02% | 22.62% | 3.98% | 19 | 26.67% | 15 | -21.05% |
| 30 Jun, 22 | 41 | -21.15% | 10,845,225 | -11.60% | 23.83% | 3.28% | 15 | -40.00% | 19 | 26.67% |
| 31 Mar, 22 | 52 | -11.86% | 12,268,809 | -19.22% | 26.97% | 2.14% | 25 | -16.67% | 15 | -11.76% |
| 31 Dec, 21 | 59 | -20.27% | 15,188,388 | -1.32% | 35.53% | 3.10% | 30 | -9.09% | 17 | -15.00% |
| 30 Sep, 21 | 74 | -9.76% | 15,391,141 | -5.08% | 33.85% | 2.66% | 33 | 17.86% | 20 | -41.18% |
| 30 Jun, 21 | 82 | -1.20% | 16,214,576 | 6.38% | 35.67% | 2.77% | 28 | -39.13% | 34 | 88.89% |
| 31 Mar, 21 | 83 | -10.75% | 15,242,597 | -6.59% | 35.86% | 2.44% | 46 | -14.81% | 18 | -25.00% |
| 31 Dec, 20 | 93 | 25.68% | 16,317,915 | 14.74% | 38.31% | 3.42% | 54 | 92.86% | 24 | -20.00% |
| 30 Sep, 20 | 74 | -7.50% | 14,221,871 | 2.26% | 33.47% | 3.12% | 28 | -41.67% | 30 | 36.36% |
| 30 Jun, 20 | 80 | 25.00% | 13,907,451 | -3.69% | 32.74% | 2.83% | 48 | 41.18% | 22 | 29.41% |
| 31 Mar, 20 | 64 | 4.92% | 14,439,722 | 9.19% | 34.02% | 3.51% | 34 | 17.24% | 17 | - |
| 31 Dec, 19 | 61 | 1.67% | 13,224,530 | 0.58% | 31.15% | 3.25% | 29 | -9.38% | 17 | 13.33% |
| 30 Sep, 19 | 60 | -16.67% | 13,148,144 | -2.14% | 30.98% | 3.09% | 32 | -8.57% | 15 | -37.50% |
| 30 Jun, 19 | 72 | 12.50% | 13,435,839 | 5.46% | 31.66% | 3.24% | 35 | -10.26% | 24 | 71.43% |
| 31 Mar, 19 | 64 | -3.03% | 12,740,164 | 10.91% | 31.25% | 3.94% | 39 | 25.81% | 14 | -33.33% |
| 31 Dec, 18 | 66 | -19.51% | 11,487,276 | -0.19% | 28.17% | 3.83% | 31 | -26.19% | 21 | 10.53% |
| 30 Sep, 18 | 82 | -5.75% | 11,509,673 | 2.15% | 27.14% | 3.81% | 42 | -23.64% | 19 | 46.15% |
| 30 Jun, 18 | 87 | 24.29% | 11,267,379 | 59.78% | 26.69% | 6.84% | 55 | 30.95% | 13 | -7.14% |
| 31 Mar, 18 | 70 | 12.90% | 7,051,731 | -3.51% | 19.76% | 4.71% | 42 | 31.25% | 14 | 40.00% |
| 31 Dec, 17 | 62 | 29.17% | 7,308,296 | 24.45% | 20.48% | 7.66% | 32 | 39.13% | 10 | 11.11% |
| 30 Sep, 17 | 48 | 11.63% | 5,872,447 | 11.67% | 16.35% | 7.48% | 23 | 21.05% | 9 | -18.18% |
| 30 Jun, 17 | 43 | 2.38% | 5,258,929 | -7.79% | 14.79% | 5.68% | 19 | 11.76% | 11 | 22.22% |
| 31 Mar, 17 | 42 | 10.53% | 5,703,192 | 0.58% | 16.14% | 6.27% | 17 | -5.56% | 9 | - |
| 31 Dec, 16 | 38 | -7.32% | 5,670,274 | -14.59% | 16.05% | 4.55% | 18 | 12.50% | 9 | -10.00% |
| 30 Sep, 16 | 41 | 5.13% | 6,638,842 | -4.24% | 18.79% | 4.87% | 16 | -11.11% | 10 | 11.11% |
| 30 Jun, 16 | 39 | -11.36% | 6,932,864 | 7.10% | 19.64% | 5.84% | 18 | - | 9 | -30.77% |
| 31 Mar, 16 | 44 | -6.38% | 6,473,069 | -8.20% | 18.34% | 4.55% | 18 | -35.71% | 13 | 18.18% |
| 31 Dec, 15 | 47 | 9.30% | 7,051,276 | 2.53% | 20.07% | 5.23% | 28 | 40.00% | 11 | 10.00% |
| 30 Sep, 15 | 43 | 7.50% | 6,877,612 | 4.19% | 19.60% | 5.52% | 20 | -25.93% | 10 | 66.67% |
| 30 Jun, 15 | 40 | -9.09% | 6,601,328 | 7.79% | 18.84% | 6.17% | 27 | -38.64% | 6 | - |
| 31 Mar, 15 | 44 | - | 6,124,469 | - | 17.48% | - | 44 | - | - | - |
Cellectis Peer Ownership
| Ticker | Company |
|---|---|
| SLNO | Soleno Therapeutics, Inc. |
| NRIX | Nurix Therapeutics, Inc. |
| CYT | Cyteir Therapeutics, Inc. |
| KYMR | Kymera Therapeutics, Inc. |
| FHTX | Foghorn Therapeutics Inc. |
| INBX | Inhibrx, Inc. |
| RGNX | REGENXBIO Inc. |
| LIAN | LianBio |
| ERYP | PHAXIAM Therapeutics S.A. |
| SGTX | Sigilon Therapeutics, Inc. |
| PASG | Passage Bio, Inc. |
| CRNX | Crinetics Pharmaceuticals, Inc. |
| IPHA | Innate Pharma S.A. |
| HCWB | HCW Biologics Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| DMAC | DiaMedica Therapeutics Inc. |
| GNFT | Genfit S.A. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| KZR | Kezar Life Sciences, Inc. |
| STTK | Shattuck Labs, Inc. |
| ELYM | Eliem Therapeutics, Inc. |
CLLS Ownership FAQ
Who Owns Cellectis?
Cellectis is owned by institutional shareholders (2.30%), insiders (9.39%), and public (88.31%). The largest institutional shareholder of Cellectis is LONG FOCUS CAPITAL MANAGEMENT, LLC (6.43% of total shares) and the top mutual fund owner is EntrepreneurShares Series Trust (0.64% of total shares).
Who are the major institutional shareholders of Cellectis?
Cellectis's major institutional shareholders are LONG FOCUS CAPITAL MANAGEMENT, LLC, CAPITAL INTERNATIONAL INVESTORS, UBS ASSET MANAGEMENT AMERICAS INC, BAILLIE GIFFORD & CO, and PRINCIPAL FINANCIAL GROUP INC. The top five shareholders own together 12.60% of the company's share outstanding.
How many Cellectis shareholders are there?
As of Jun 2024, there are 11 institutional shareholders of Cellectis.
What percentage of Cellectis is owned by LONG FOCUS CAPITAL MANAGEMENT, LLC?
LONG FOCUS CAPITAL MANAGEMENT, LLC owns 4.62M shares of Cellectis, representing 6.43% of the company's total shares outstanding, valued at $8.63M (as of Jun 2024).
What percentage of Cellectis is owned by CAPITAL INTERNATIONAL INVESTORS?
As of Jun 2024, CAPITAL INTERNATIONAL INVESTORS holds 1.85M shares of Cellectis (CLLS), compromising 2.57% of the company, valued at $3.46M.
What percentage of Cellectis is owned by UBS ASSET MANAGEMENT AMERICAS INC?
UBS ASSET MANAGEMENT AMERICAS INC is the third largest holder of Cellectis. The company owns 1.44M of the company's shares outstanding (worth $2.69M).